Truist raises Axsome Therapeutics stock target to $190 on Symbravo approval
Truist Securities adjusted their financial outlook for Axsome Therapeutics (NASDAQ:AXSM), increasing the price target to $190 from the previous $180 while maintaining a Buy rating on the company's ...
RBC Bearings price target raised to $410 from $351 at Truist
Truist analyst Michael Ciarmoli raised the firm’s price target on RBC Bearings (RBC) to $410 from $351 and keeps a Buy rating on the shares ...
Hosted on MSN2d
Do Wall Street Analysts Like Truist Financial Stock?
Truist Financial Corporation (TFC), headquartered in Charlotte, North Carolina, is a leading financial services provider ...
Arthur J. Gallagher price target raised to $290 from $275 at Truist
Truist analyst Mark Hughes raised the firm’s price target on Arthur J. Gallagher (AJG) to $290 from $275 and keeps a Hold rating on the shares.